GSK3B and gastric cancer: Western blotting results showed that MK2206 treatment of GC cells overexpressing ACTN1 significantly inhibited the GSK3β phosphorylation, β-catenin and EMT transcription inhibitor Snail expression, whereas enhanced β-catenin phosphorylation (Figure 7c).